Table 4.
Overall | Hepatocellular Carcinoma Due to Hepatitis B | Hepatocellular Carcinoma Due to Hepatitis C | Hepatocellular Carcinoma Due to Alcohol Use | Hepatocellular Carcinoma Due to NASH | Hepatocellular Carcinoma Due to Other Cause | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Mortality Number (95% UI) | ASMR per 100,000 (95% UI) | Mortality Number (95% UI) | ASMR Per 100,000 (95% UI) | Mortality Number (95% UI) | ASMR Per 100,000 (95% UI) | Mortality Number (95% UI) | ASMR Per 100,000 (95% UI) | Mortality Number (95% UI) | ASMR Per 100,000 (95% UI) | Mortality Number (95% UI) | ASMR Per 100,000 (95% UI) | |
Both | 172,068.40 (139,621.29, 212,495.94) | 8.35 (6.80, 10.29) | 100,193.63 (77,721.19, 129,138.37) | 4.83 (3.76, 6.19) | 34,899.08 (27,412.63, 42,964.74) | 1.74 (1.38, 2.12) | 18,371.09 (13,652.97, 24,251.63) | 0.85 (0.64, 1.12) | 10,409.34 (8036.34. 13,179.82) | 0.51 (0.39, 0.64) | 8033.49 (13,652.97, 24,251.63) | 0.39 (0.30, 0.49) |
Femlae | 49,605.44 (38,616.99, 62,668.34) | 4.57 (2.57, 5.76) | 15,128.73 (11,158.75, 19,855.58) | 1.40 (1.04, 1.84) | 19,635.40 (15,057.49, 24,848.52) | 1.80 (1.39, 2.28) | 6118.90 (4471.69, 8144.01) | 0.54 (0.40, 0.73) | 4894.87 (3668.73, 6557.52) | 0.45 (0.34, 0.60) | 3735.44 (2761.27, 4949.11) | 0.35 (0.26, 0.46) |
Male | 122,462.95 (93,115.19, 164,815.76) | 12.40 (9.46, 16.55) | 85,064.90 (63,905.26, 114,759.77) | 8.48 (6.42, 11.29) | 15,263.68 (11,223.29, 20,714.20) | 1.69 (1.27, 2.26) | 12,198.19 (8488.63, 17,015.00) | 1.19 (0.85, 1.62) | 5514.47 (3894.58, 7542.17) | 0.58 (0.41, 0.78) | 4298.05 (3031.95, 6204.21) | 0.43 (0.31, 0.62) |
UI: uncertainty interval; NASH: Non-alcoholic steatohepatitis; ASMR: age-standardized mortality rate.